Month: April 2022

Fireside Chat Replay from B. Riley Securities’ Virtual Neuro and Ophthalmology Conference on 4/27/2022

Seelos Therapeutics, Inc. (Nasdaq: SEEL) Chairman and CEO, Raj Mehra, Ph.D., and Chief Medical Officer, Tim Whitaker, MD, participated in a fireside chat at B. Riley Securities’ Virtual Neuro and Ophthalmology Conference on Wednesday, April 27th at 12:00 PM ET. https://www.webcaster4.com/Webcast/Page/2875/45355

Fireside Chat Replay: Current Treatment of Acute Suicidal Ideation and Behavior and Discussion on the Market Potential for Seelos Therapeutics’ SLS-002 Program from 4/25/2022

The fireside chat featured Evan P. Cohen, MD (Montefiore St. Luke’s Cornwall in Newburgh, New York) and John Misdary, MD (Excelis Medical Associates in Tampa, FL), who discussed the stresses and associated healthcare costs psychiatric patients place on emergency department physicians and staff, specifically patients with Acute Suicidal Ideation and Behavior (ASIB). The discussion was…
Read more